Orexigen Therapeutics Inc (NASDAQ:OREX)

4.71
Delayed Data
As of 3:59pm ET
 -0.06 / -1.26%
Today’s Change
3.11
Today|||52-Week Range
9.37
-22.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line-24.5M11.3M607.0K-17.2M
 
 
 
 
 
Depreciation38.0K41.0K52.0K51.0K
 
 
 
 
 
Total Other Cash Flow4.1M4.3M7.6M3.4M
 
 
 
 
 
Funds From Operations-20.4M15.6M8.3M-13.8M
 
 
 
 
 
Funds From/For Other Operating Expenses1.6M31.1M-77.9M5.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-21.9M-15.5M86.2M-19.6M
 
 
 
 
 
 
InvestingIncrease In Investments-1.3M-13.4M-65.6M-37.6M
 
 
 
 
 
Decrease In Investments16.4M65.2M14.4M25.1M
 
 
 
 
 
Capital Expenditures-63.0K-84.0K-71.0K-11.0K
 
 
 
 
 
Net Cash Flow Investing15.1M51.7M-51.3M-12.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00--0.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale398.0K1.1M1.0M3.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing398.0K1.1M1.0M3.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.00----
 
Net Change In Cash-6.5M37.3M35.9M-29.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account